Overall survival (OS) in patients (pts) with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP): A real-world retrospective study.

被引：1
|
作者：
Hennenfent, Kristin L.
Girvan, Allicia C.
Chaudhry, Aafia
Abada, Paolo
Sheffield, Kristin
Herren, Catherine K.
Raju, Aditya
Farrelly, Eileen
Bowman, Lee
Landsman-Blurnberg, Pamela
机构：
[1] Xcenda, Kansas City, MO USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Eli Lilly & Co, Bridgewater, NJ USA
[4] Xcenda, Palm Harbor, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15658
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15658
引用
收藏
页数：5
相关论文
共 50 条
  • [1] The role of alpha-fetoprotein (AFP) in monitoring of treatment and prediction of survival in patients with hepatocellular carcinoma (HCC).
    Kim, SR
    Kim, HJ
    Kim, YJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 355S - 355S
  • [2] Association between post-treatment (tx) alpha-fetoprotein (AFP) reduction and outcomes in real-world (rw) US patients (pts) with advanced HCC (aHCC).
    Wang, Xiaoliang
    Magee, Kelly
    Gossai, Anala
    Parrinello, Christina M.
    Miksad, Rebecca A.
    Kim, Richard D.
    Abou-Alfa, Ghassan K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [3] Changes in alpha-fetoprotein (AFP) and systemic therapy outcomes in advanced hepatocellular carcinoma (HCC): A multicenter retrospective analysis.
    Bocobo, Andrea Grace
    Bracci, Paige M.
    Parks, Anna
    Hannan, Lindsay Marie
    Bauer, Kelly
    Goyal, Lipika
    Gordan, John Dozier
    Venook, Alan P.
    Harris, William Proctor
    Kelley, Robin Kate
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [4] Ramucirumab in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): An exposure-response analysis
    Llovet, J.
    Kudo, M.
    Kang, Y-K.
    Yen, C-J.
    Finn, R. S.
    Galle, P. R.
    Assenat, E.
    Motomura, K.
    Okusaka, T.
    Berg, T.
    Hsu, C-H.
    Ikeda, M.
    Hsu, Y.
    Liang, K.
    Widau, R.
    Schelman, W.
    O'Brien, L.
    Gao, L.
    Zhu, A. X.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 293 - +
  • [5] Impact of baseline hepatitis B viremia and management on outcomes in patients (Pts) with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP): Outcomes from REACH-2
    Galle, Peter R.
    Kudo, Masatoshi
    Llovet, Josep M.
    Finn, Richard S.
    Karwal, Mark
    Pezet, Denis
    Kim, Tae-You
    Yang, Tsai-Sheng
    Zagonel, Vittorina
    Tomasek, Jiri
    Phelip, Jean Marc
    Touchefeu, Yann
    Koh, Su-Jin
    Stirnimann, Guido
    Wang, Chunxiao
    Ogburn, Kenyon
    Abada, Paolo
    Widau, Ryan C.
    Zhu, Andrew X.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [6] PROLONGED SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) PRESENTING WITH ALPHA-FETOPROTEIN LEVELS
    MELIA, WM
    JOHNSON, PJ
    WILLIAMS, R
    [J]. GUT, 1979, 20 (05) : A460 - A460
  • [7] Is serum alpha-fetoprotein (AFP) a useful screening marker for hepatocellular carcinoma (HCC) in patients of cirrhosis?
    Paul, Shashi B.
    Acharya, Subrat K.
    Sreenivas, V.
    Gulati, Manpreet S.
    Madan, Kaushal
    Gupta, Arun K.
    Mukhopadhyay, Sima
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A466 - A466
  • [8] Association between prothrombin rate, alpha-fetoprotein changes and survival of patients with advanced hepatocellular carcinoma (HCC)
    Mauguen, A.
    Michiels, S.
    Bonnetain, F.
    Barbare, J.
    Bouche, O.
    Doffoel, M.
    Bedenne, L.
    Paoletti, X.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] REAL-WORLD EXPERIENCE OF NIVOLUMAB THERAPY FOR ADVANCED HEPATOCELLULAR CARCINOMA IN TAIWAN: EARLY REDUCTION OF SERUM ALPHA-FETOPROTEIN ASSOCIATED WITH THERAPEUTIC RESPONSE AND OVERALL SURVIVAL
    Lin, Chen-Chun
    Lin, Shi-Ming
    Hou, Ming-Mo
    Lui, Kar-Wai
    Teng, Wei
    Wang, Sheng-Fu
    Hsu, Chao-Wei
    [J]. HEPATOLOGY, 2019, 70 : 538A - 539A
  • [10] Safety of ramucirumab treatment in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein
    Yen, Chih-Chieh
    Yen, Chia-Jui
    [J]. EXPERT OPINION ON DRUG SAFETY, 2022, 21 (02) : 157 - 166
12345